United States · FDA National Drug Code directory
Clindamycin hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76420-202_fab215a4-0e6e-767a-e053-6294a90a89ed
- Product NDC
- 76420-202
- Form
- CAPSULE
- Composition / generic term
- Clindamycin hydrochloride
- Labeler
- Asclemed USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20010323
- Source listing expiry
- 20261231
Source-listed ingredients
- CLINDAMYCIN HYDROCHLORIDE — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (76420-202-01) · 76420-202-01
- 12 CAPSULE in 1 BOTTLE (76420-202-12) · 76420-202-12
- 20 CAPSULE in 1 BOTTLE (76420-202-20) · 76420-202-20
- 30 CAPSULE in 1 BOTTLE (76420-202-30) · 76420-202-30
- 60 CAPSULE in 1 BOTTLE (76420-202-60) · 76420-202-60
- 90 CAPSULE in 1 BOTTLE (76420-202-90) · 76420-202-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →